ALISON TURKOWSKI: Open Payments
NPI 1760856835 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 61 payments from 15 companies in 2025. Trend: 2023 $789 · 2024 $1,038 · 2025 $1,318
Food & beverage: $1,228Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $296 |
| Janssen Biotech, Inc. | 10 | $254 |
| Galderma Laboratories, L.P. | 8 | $157 |
| Amgen Inc. | 5 | $108 |
| GENZYME CORPORATION | 4 | $100 |
| Incyte Corporation | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Organon LLC | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| LEO Pharma Inc. | 2 | $42 |
Products named: TREMFYA, RINVOQ, NEMLUVIO, DUPIXENT, Otezla, SKYRIZI, OPZELURA, Sotyktu.
Industry payments across CT — which companies pay providers there.
